-
Ortho-McNeil Pharmaceutical, Inc. v. Apotex, Inc. DC
- 1:07-cv-04050
- N.D. Ill.
- Judge: Rebecca R. Pallmeyer
- Filed: 07/18/2007
- Closed: 07/20/2010
- Latest Docket Entry: 07/20/2010
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
1
Patent-in-Suit
1,099
Days in
Litigation
-
Ortho-McNeil Pharmaceutical, Inc. v. Apotex, Inc. DC
- 1:07-cv-04050
- N.D. Ill.
- Judge: Rebecca R. Pallmeyer
- Filed: 07/18/2007
- Closed: 07/20/2010
- Latest Docket Entry: 07/20/2010
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
43 |
<?insert-start id="INS-S-00032" date="20060801" ?>43. A pharmaceutical composition comprising an active ingredient that consists essentially of tramadol and acetaminophen, wherein the ratio of tramadol to acetaminophen is a weight ratio from about
view more
|
Enforceable and Valid
Entry 141 |
44 |
<?insert-start id="INS-S-00033" date="20060801" ?>44. The pharmaceutical composition of claim 43 wherein the tramadol is racemic.<?insert-end id="INS-S-00033" ?>
|
Enforceable and Valid
Entry 141 |
45 |
<?insert-start id="INS-S-00034" date="20060801" ?>45. The pharmaceutical composition of claim 43 wherein the tramadol is present as its hydrochloride salt.<?insert-end id="INS-S-00034" ?>
|
Enforceable and Valid
Entry 141 |
46 |
<?insert-start id="INS-S-00035" date="20060801" ?>46. The pharmaceutical composition of claim 45 wherein the tramadol hydrochloride is racemic.<?insert-end id="INS-S-00035" ?>
|
Enforceable and Valid
Entry 141 |
47 |
<?insert-start id="INS-S-00036" date="20060801" ?>47. The pharmaceutical composition of claim 43 wherein said active ingredient consists essentially of an admixture of said tramadol and said acetaminophen.<?insert-end id="INS-S-00036" ?>
|
Enforceable and Valid
Entry 141 |
48 |
<?insert-start id="INS-S-00037" date="20060801" ?>48. The pharmaceutical composition of claim 43 comprising a pharmaceutically acceptable carrier.<?insert-end id="INS-S-00037" ?>
|
Enforceable and Valid
Entry 141 |
51 |
<?insert-start id="INS-S-00040" date="20060801" ?>51. The pharmaceutical composition of claim 43 that is in the form of a tablet.<?insert-end id="INS-S-00040" ?>
|
Enforceable and Valid
Entry 141 |
54 |
<?insert-start id="INS-S-00043" date="20060801" ?>54. A method for treating pain in a mammal comprising administering to the mammal an effective amount of the pharmaceutical composition of claim 43.<?insert-end id="INS-S-00043" ?>
|
Enforceable and Valid
Entry 141 |
67 |
<?insert-start id="INS-S-00056" date="20060801" ?>67. A pharmaceutical composition consisting essentially of: <i>an active ingredient that consists of racemic tramadol hydrochloride and acetaminophen, wherein the ratio of racemic tramadol
view more
|
Enforceable and Valid
Entry 141 |
69 |
<?insert-start id="INS-S-00058" date="20060801" ?>69. The pharmaceutical composition of claim 67 that is in the form of a tablet.<?insert-end id="INS-S-00058" ?>
|
Enforceable and Valid
Entry 141 |
72 |
<?insert-start id="INS-S-00061" date="20060801" ?>72. A method for treating pain in a mammal comprising orally administering to the mammal an effective amount of the pharmaceutical composition of claim 67.<?insert-end id="INS-S-00061" ?>
|
Enforceable and Valid
Entry 141 |
74 |
<?insert-start id="INS-S-00063" date="20060801" ?>74. A method for treating pain in a mammal comprising orally administering to the mammal an effective amount of the pharmaceutical composition of claim 69.<?insert-end id="INS-S-00063" ?>
|
Enforceable and Valid
Entry 141 |